论文信息 - A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease. - 字舞流文

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease.

M. Arbushites | J. Dipersio | M. Perales | H. Khoury | Yi-Bin Chen | G. Schiller | M. Jagasia | P. Langmuir | Leah N Gehrs | M. Pratta | M. Schroeder | H. Ali | N. Srinivas | Ying Yan | Jaebok Choi | G. Meyers | K. Staser | Leah Gehrs | H. Khoury | Mark A. Schroeder